Research helps the medical community better understand diseases and can lead to advances in diagnosis
and treatments. The knowledge gained through your participation in the CARDINAL clinical trial may
ultimately benefit many patients by helping to identify safe and effective medicines for patients
with Alport syndrome.
The ethics and laws that govern medical practice also apply to clinical studies. A process called informed
consent ensures you know all the facts regarding the study (including potential side effects), the investigational
drug, and your condition. If you decide to participate, you will sign an informed consent document.
However, you may withdraw from the study at any time, for any reason.
If you choose to participate the study team, including the study doctor and his or her staff, will manage
your study-related care throughout your participation. You will be encouraged to continue seeing
your regular doctor for routine care.
The CARDINAL study sponsor will provide the investigational drug, study-related procedures, and doctor
visits will be provided at no cost. You may be compensated for your time and travel, including airline and
lodging costs, if these are needed.